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Abstract 
 
Bipolar disorder is often unrecognized and misdiagnosed in the general psychiatric 
setting. This study compared the psychometric properties of Mood Disorder 
Questionnaire (MDQ) and Hypomania Checklist-32 (HCL-32), examined the clinical 
predictors of bipolar disorder, and determined the best approach for screening 
previously unrecognized bipolar disorder in a general psychiatric clinic. A random 
sample of 340 non-psychotic outpatients with no previous diagnosis of bipolar 
disorder completed the MDQ and HCL-32 during their scheduled clinic visits. Mood 
and alcohol/substance use disorders were re-assessed using a telephone-based 
Structured Clinical Interview for DSM-IV. We found that the HCL-32 had better 
psychometric performance and discriminatory capacity than the MDQ. The HCL-32’s 
internal consistency and 4-week test-retest reliability were higher. The area under 
curve was also greater than those of MDQ at various clustering and impairment 
criteria. The optimal cut-off of MDQ was co-occurrence of 4 symptoms with omission 
of impairment criterion; for HCL-32, it was 11 affirmative responses. Multivariable 
logistic regression found that bipolar family history was associated with an increased 
risk of bipolar disorder (odds ratio = 4.93). The study showed that simultaneous use of 
HCL-32 and bipolar family history was the best approach for detecting previously 
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unrecognized bipolar disorder. 
 
Keywords: bipolar disorder, bipolar spectrum disorder, Chinese, detection, 
Hypomania Checklist, Mood Disorder Questionnaire, screening 
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1. Introduction  
 
In recent years, there has been emerging evidence supporting the dimensional concept 
of bipolar disorder (Akiskal and Pinto, 1999). Bipolar spectrum disorder represents a 
continuum of mood changes of different severities ranging between full blown mania 
and unipolar depression (Katzow et al., 2003). It consists of not only bipolar I and 
bipolar II, but also cyclothymia and bipolar disorder not otherwise specified (bipolar 
NOS), which includes a heterogeneous group of clinically significant bipolar 
conditions not meeting the DSM-IV criteria (American Psychiatric Association, 2000). 
Bipolar disorder, especially the milder forms (bipolar II and bipolar NOS), is often 
unrecognized and misdiagnosed in clinical practice (Ghaemi et al., 2002). 
Identification of past history of hypomania can be difficult, as a majority of patients 
seek treatment during their depressive rather than hypomanic episodes (Hirschfeld, 
2001). Up to 69% of bipolar patients were initially misdiagnosed and most frequently 
as unipolar depression, followed by anxiety disorders, personality disorders and 
substance or alcohol use disorders, due to overlapping symptomatology (Hirschfeld et 
al., 2003). Correct diagnosis and treatment can be delayed by 8 to 10 years (Lish et al., 
1994). Under-recognition of bipolar disorder results in substantial negative impact on 
individual patients and the whole society. It is associated with higher suicide rate, 
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poorer quality of life, greater functional impairment and increased healthcare cost (Shi 
et al., 2004; Matza et al., 2005; Awad et al., 2007). Inappropriate antidepressant 
monotherapy is less effective in treating bipolar depression, and it also increases the 
risk of manic switch and cycle acceleration (Dunner, 2003). The clinical significance 
of subthreshold bipolar conditions is increasingly recognized on the basis of higher 
illness severity, suicidality, disability and healthcare utilization comparable to bipolar 
I and II disorders (Judd and Akiskal, 2003; Merikangas et al., 2007). Hence, early 
detection and correct treatment of bipolar disorder is very important.  
 
The use of clinical predictors and screening instruments can improve the recognition 
of bipolar disorder (Phelps and Ghaemi, 2006). Benazzi (2004) has found that bipolar 
family history and early age of onset are the two most significant bipolar validators; 
early onset has the highest sensitivity and bipolar family history has the highest 
specificity. The most widely used screening instruments for bipolar disorder include 
Mood Disorder Questionnaire (MDQ) and Hypomania Checklist-32 (HCL-32). The 
MDQ is a single-page self-report questionnaire consisting of three sections (symptom 
endorsement of 13 items, symptom clustering, and level of functional impairment). In 
the original validation study in a psychiatric population, the standard cut-off criterion 
is a clustering of at least 7 symptoms with at least moderate level of impairment, 
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where sensitivity is 0.73 and specificity is 0.90 (Hirschfeld et al., 2000). The HCL-32 
is another self-administered questionnaire comprising of a checklist of 32 yes/no 
questions to screen for past hypomanic symptoms (Angst et al., 2005). The standard 
cut-off score is 14, yielding a sensitivity of 0.80 and specificity of 0.51. Although 
HCL-32 was originally developed for use in depressed patients, it could be useful in 
non-clinical and non-specialized psychiatric settings (Meyer et al., 2007). 
 
Previous studies on the screening performance of MDQ and HCL-32 have focused on 
patients with mood disorders in specialized clinics. Little is known about the 
performance of these screening tools in detecting previously unrecognized bipolar 
disorder, of which inappropriate treatment and functional impairment are common. 
There has not been any study examining the clinical predictors of bipolar disorder 
among Chinese. In this study, firstly, we examined the psychometric properties of 
MDQ and HCL-32 in a representative sample of general psychiatric outpatients who 
had not been previously received a bipolar disorder diagnosis. Secondly, we identified 
the clinical predictors of bipolar disorder; and lastly, we found out the best method for 
screening previously unrecognized bipolar disorder by comparing the performance of 
MDQ, HCL-32, and a combination of MDQ and HCL-32 with clinical predictors. 
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2. Methods  
 
This study was conducted in a regional psychiatric clinic in Hong Kong. It was 
reviewed and approved by the local institutional review board.  
 
2.1 Participants  
 
The sample size calculation was based on previous sensitivity and specificity values 
of the Chinese MDQ (Chung et al., 2008) and the Taiwanese HCL-32 (Wu et al., 
2008), and the local prevalence of bipolar disorder (Mak, 2009). Setting the level of 
significance at 0.05 and the acceptable width of 95% confidence interval for 
sensitivity and specificity at 8%, calculation using the prior sensitivity of MDQ  
yielded the largest sample size, where the number of subjects was estimated at 330 
(Buderer, 1996). Assuming an overall refusal rate of 25%, 450 subjects would be 
sufficient to achieve statistically significant results on the accuracy of MDQ and 
HCL-32. 
 
The inclusion criteria were ethnic Chinese, aged 18 to 64 years, and no previous 
diagnosis of bipolar disorder, psychotic disorders, mental retardation, dementia, and 
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organic mental disorders. A complete list of outpatients who had visited the clinic 
between 1 March 2008 and 30 June 2008 was generated from the computerized 
patient record system. From 6108 active cases, 3534 patients satisfied the inclusion 
criteria. A total of 450 subjects were selected through a simple randomization process 
using computer-generated random numbers. Three-hundred forty subjects gave 
informed consent and completed the questionnaires while 110 patients did not 
participate (89 refused and 21 were excluded due to illiteracy). From the 
computerized record, the original psychiatric diagnoses of the 340 participants were 
as follows: 49.4% (n = 168) had major depressive disorder; 11.5% (n = 39) had 
generalized anxiety disorder; 9.4% (n = 32) had mixed anxiety and depressive 
disorder; 8.8% (n = 30) had adjustment disorder; 7.1% (n = 24) had panic or phobic 
disorder; 5.9% (n = 20) had dysthymic disorder, 3.2% (n = 11) had 
obsessive-compulsive disorder; 4.7% (n = 16) had alcohol or substance use disorder; 
2.1% (n = 7) had post-traumatic stress or acute stress disorder; 1.8% (n = 6) had 
primary insomnia; and 1.5% (n = 5) had personality disorder. Only 16 (4.7%) of the 
340 participants were given more than 1 psychiatric diagnosis. Major depressive 
disorder comorbid alcohol or substance use disorder, which was diagnosed in 6 
subjects, was the most common form of psychiatric comorbidity. There was no 
significant difference in age, gender, marital status, and psychiatric diagnosis by 
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medical record between the 340 participants and the 110 non-participants. 
 
2.2 Measures  
 
The Chinese version of MDQ was used. The process of translation from English into 
Chinese was reported in details in a previous study (Chung et al., 2008). The 
Taiwanese version of HCL-32 was obtained with approval from one of the authors of 
the Taiwanese study (RBL) (Wu et al., 2008). Due to differences of language and 
terminology use in Cantonese (Hong Kong) and Mandarin (Taiwan), some items in 
the Taiwanese version were modified. The comprehension of each item was reviewed 
by an expert panel consisting of four bilingual psychiatrists (YP, KFC, KCT and CLC) 
and amended accordingly. It was tested in a pilot sample of 16 clinically stable 
patients. Four items (question 2, items 6 and 20 of question 3, and question 5) 
required further modifications. The final Chinese (Hong Kong) version of HCL-32 
was then re-edited and approved by the expert panel for use in this study.  
 
The subjects’ psychiatric diagnoses were re-assessed using a telephone-based Chinese 
version of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) 
(First et al., 2002; So et al., 2003). Only the modules of mood and substance use 
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disorders were used. To improve the assessment of past hypomania, we ignored the 
skip-out instruction of the screening question on mood (Benazzi and Akiskal, 2003). 
The diagnosis of all bipolar subtypes was based on the DSM-IV-TR criteria. Bipolar 
NOS refers to brief hypomania meeting the DSM-IV-TR symptom criteria, lasting for 
2 to 4 days, and having at least 1 major depressive episode. Our definition of bipolar 
NOS has been validated and used in previous studies (Akiskal and Benazzi, 2005; 
Benazzi and Akiskal, 2006; Kim et al., 2008; Lee et al., 2009). 
 
2.3 Procedure  
 
The authors contacted the participants during their scheduled clinic visits. Written 
informed consent was obtained from all subjects and they were asked to complete a 
demographic and clinical information sheet and the Chinese version of MDQ and 
HCL-32. Clinical information included family history of depression and bipolar 
disorder in first-degree relatives and age of onset of illness, defined as age when 
patients first had mood symptoms that caused clinically significant distress or 
functional impairment. Early onset was defined as onset of illness <21 years, which 
was the most validated and commonly used cut-off (Benazzi and Akiskal, 2008; Mak, 
2009). 
  
 
11 
  
The subjects were then contacted by telephone within 2 weeks upon questionnaire 
completion. The author (YP) who was trained and experienced in using SCID and was 
blind to the patients’ MDQ and HCL-32 results and their original psychiatric 
diagnoses conducted the diagnostic interview and further verified with patients the 
clinical information reported on the questionnaire. 
 
We assessed the inter-rater reliability of the SCID-derived lifetime diagnosis in 20 
consecutive patients. Three psychiatrists (YP, KFC and KCT) referred to 
audio-recorded interviews and independently rated whether the patients had a lifetime 
diagnosis of bipolar disorder, major depressive disorder, or other diagnoses. The 
kappa and Yule’s coefficients (Helzer et al., 1985) for all diagnostic categories were 
1.00, suggesting excellent agreement among the raters. Previous studies have shown 
that telephone SCID interview is comparable to face-to-face interview in diagnostic 
assessments for lifetime psychiatric diagnoses (Cacciola et al., 1999; Crippa et al., 
2008), and it can increase participation rate when face-to-face interview is not feasible 
(Allen et al., 2003). We examined the level of agreement in the SCID-derived lifetime 
diagnosis between telephone and face-to-face interview in a convenient sample of 20 
patients; both the kappa and Yule’s coefficients were 1.00, suggesting that the two 
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methods were highly comparable. 
 
We assessed the test-retest reliability of MDQ and HCL-32 by asking a consecutive 
sample of 180 patients to complete the scales twice over 4 weeks. The second set of 
scales was posted to the subjects about 3 weeks after the day of recruitment. Only 109 
patients returned the questionnaires, and 2 were excluded as the scales were 
completed later than 6 weeks after the first test. The test-retest reliability was 
examined in 107 patients. The mean time between the first and second questionnaire 
administration was 29.7 days (range = 20-42 days).  
 
2.4 Data analysis  
 
All statistical analysis was done by SPSS version 15.0 for Windows (SPSS, Chicago, 
USA). Categorical variables were analyzed by Chi-square or Fisher exact test. Due to 
the lack of normal distribution, continuous variables were analyzed by Mann-Whitney 
U test. P value <0.05 was considered statistically significant. 
 
The internal consistency of MDQ and HCL-32 was evaluated by Cronbach’s alpha. 
Test-retest reliability was assessed by intraclass correlation coefficient (ICC). The 
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discriminatory capacity was evaluated in terms of sensitivity, specificity, positive 
predictive value (PPV), negative predictive value (NPV), and likelihood ratio for 
positive and negative tests (LR(+) and LR(-)). Receiver-operating-characteristic 
(ROC) analysis was used to compare the discriminatory capacity of MDQ and 
HCL-32. The optimal cut-off was the point closest to the left upper corner of the ROC 
curve and the discriminatory power was measured by the area under curve (AUC) 
(Chu, 1999). 
 
Based on the SCID-derived diagnosis, subjects were divided into bipolar and 
non-bipolar groups. The two groups were compared on demographic and clinical 
variables. Univariate and multivariable logistic regression were used to identify the 
clinical correlates indicative of bipolar disorder by controlling for possible 
demographic confounders. The most validated bipolar predictors found in previous 
studies, including bipolar family history in first-degree relatives and age of onset of 
illness <21 years were entered as independent variables; while diagnosis of bipolar 
disorder was the dependent variable. 
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3. Results  
 
Of the 340 subjects who completed the questionnaires, 16 refused the telephone-based 
SCID interview and we were unable to contact 19 subjects by telephone. There was 
no significant difference in demographics, clinical variables, psychiatric diagnosis by 
medical record, and median MDQ and HCL-32 scores between the 305 respondents 
and 35 non-respondents of SCID. 
 
3.1 Sample description  
 
The median age of the 340 participants was 50.0 years (range = 18-64); 66.8% were 
female. About two-thirds were married or cohabited and 65.0% had secondary 
educational level or above. Ninety-four subjects (27.6%) were professional, 
semi-professional or clerical worker; 74 (21.8%) were manual worker, 88 (25.9%) 
were homemaker, and 84 (24.7%) were unemployed. The median age of onset of 
illness was 37.5 years (range = 10-62) and the median duration of illness was 9.0 
years (range = 1-44). Sixty-eight participants (20.0%) had family history of 
depressive disorder in their first-degree relatives; while 27 (7.9%) had bipolar family 
history. 
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Based on the telephone-based SCID, 31 (10.2%) of the 305 subjects were 
re-diagnosed to have a lifetime DSM-IV bipolar disorder, in which 14 (4.6%) were 
bipolar II and 17 (5.6%) were bipolar NOS. All bipolar NOS subjects reported to have 
a history of brief hypomania lasting for 2 to 3 days. Participants who were 
re-diagnosed with bipolar disorder included 20 patients with an initial diagnosis of 
major depressive disorder, 5 with anxiety disorders, 3 with mixed anxiety and 
depressive disorder, 1 with primary insomnia, 1 with major depressive disorder 
comorbid generalized anxiety disorder, and 1 with adjustment disorder comorbid 
personality disorder. 
 
3.2 Psychometric properties of the Chinese MDQ and HCL-32  
 
The Cronbach’s alpha of MDQ and HCL-32 were 0.75 and 0.89, respectively. In both 
questionnaires, elimination of each item did not result in a substantial increase in their 
internal consistency. The test-retest reliability (ICC) of MDQ and HCL-32 (n = 107) 
were 0.74 (95% CI: 0.64-0.81) and 0.81 (95% CI: 0.73-0.87), respectively.  
 
The ROC curves of the Chinese MDQ were compared at 6 threshold levels made up 
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of different combination of sections 2 and 3 results (Figure 1). Using the standard 
cut-off criterion, sensitivity was only 0.16 (95% CI: 0.03-0.29) and specificity was 
0.99 (95% CI: 0.98-1.00). Lowering and omission of impairment criterion increased 
the sensitivity to 0.32 and 0.39, respectively, while specificity only decreased to 0.97. 
Omission of both sections 2 and 3 increased the sensitivity to 0.42 and decreased the 
specificity to 0.93. The cut-off level that included section 2 and removed section 3 
had the highest AUC of 0.77 (95% CI: 0.67-0.87). The optimal cut-off point in our 
sample was a clustering of 4 or more positive symptoms with omission of impairment 
criterion, providing the best balance of sensitivity of 0.65 (95% CI: 0.48-0.82) and 
specificity of 0.77 (95% CI: 0.72-0.82). The PPV and NPV was 0.24 and 0.95, 
respectively. The LR(+) and LR(-) was 2.83 and 0.45, respectively. 
 
The AUC of the Chinese HCL-32 was 0.80 (95% CI: 0.72-0.88), indicating good 
discriminatory power (Figure 2). The original cut-off score of 14 only obtained a 
sensitivity of 0.68 (95% CI: 0.52-0.84) and specificity of 0.80 (95% CI: 0.75-0.85). 
From the ROC curve, the optimal cut-off score in our study was 11, yielding a 
sensitivity of 0.84 (95% CI: 0.71-0.97) and specificity of 0.70 (95% CI: 0.65-0.75), 
while the PPV was only 0.24 and the NPV was 0.98. The LR(+) and LR(-) was 2.80 
and 0.23, respectively. 
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3.3 Comparing the psychometric performance of the Chinese MDQ and HCL-32  
 
The Chinese HCL-32 had higher internal consistency (0.89 vs. 0.75) and 4-week 
test-retest reliability (0.81 vs. 0.74) than the Chinese MDQ. The AUC of HCL-32 
(0.80) was higher than those of MDQ at all threshold levels (0.53-0.77). At the 
original cut-offs of both questionnaires, HCL-32’s sensitivity (0.68) and specificity 
(0.80) fell outside the 95% confidence intervals for MDQ’s sensitivity (0.03-0.29) and 
specificity (0.98-1.00). At their optimal cut-offs, HCL-32’s sensitivity (0.84) and 
specificity (0.70) also fell outside the 95% confidence intervals for MDQ’s sensitivity 
(0.48-0.82) and specificity (0.72-0.82). Hence, HCL-32 had higher sensitivity but 
lower specificity than MDQ at both cut-off levels.  
 
3.4 Clinical predictors of bipolar disorder  
 
Subjects with SCID-derived bipolar disorder were younger and more likely to have 
educational level at secondary or above and positive bipolar family history in 
first-degree relatives than non-bipolar subjects; however, psychiatric comorbidity was 
not more common in subjects with bipolar disorder (Table 1). Univariate logistic 
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regression showed that bipolar disorder was associated with positive bipolar family 
history (OR = 4.15, 95% CI: 1.58-10.92, P = 0.004); while age of onset younger than 
21 years was not significantly associated with bipolar disorder (OR = 1.79, 95% CI: 
0.57-5.58, P = 0.32). Multivariable logistic regression showed that bipolar family 
history (OR = 4.93, 95% CI: 1.73-14.02, P = 0.003) was the only independent clinical 
factor associated with bipolar disorder after controlling for the demographic 
confounders (age and educational level). 
 
3.5 Screening of bipolar disorder using combinations of bipolar family history and 
MDQ and HCL-32 scores  
 
Table 2 presents the screening performance of different combinations of bipolar 
family history and MDQ and HCL-32 scores. Adding bipolar family history to MDQ 
increased the sensitivity from 0.65 to 0.71 but decreased the specificity from 0.77 to 
0.72, compared to MDQ alone. Adding bipolar family history to HCL-32 increased 
the sensitivity from 0.84 to 0.90 and slightly decreased the specificity from 0.70 to 
0.67, compared to HCL-32 alone. 
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4. Discussion  
 
This was the first systematic study comparing the psychometric properties of MDQ, 
HCL-32, clinical predictors and their combination in a general psychiatric outpatient 
setting. We found that both MDQ and HCL-32 were valid and reliable screening 
instruments for previously unrecognized bipolar disorder; however, the optimal 
cut-offs were different from the original criteria obtained in specialized mood disorder 
clinics. The HCL-32 was more sensitive than the MDQ in detecting hypomanic 
conditions; in addition, bipolar family history was a useful clinical predictor with high 
specificity. Compared to using MDQ, HCL-32, or bipolar family history alone, 
simultaneous use of HCL-32 and family history could achieve better sensitivity for 
detecting bipolar disorder that was previously undiagnosed. 
 
The Chinese MDQ had an internal consistency of 0.75, which was comparable to 2 
previous local studies (Chung et al., 2008; Chung et al., 2009) and a Finnish study 
(Isometsa et al., 2003). The short-term test-retest reliability was satisfactory, but lower 
than that of the Spanish MDQ (Vieta et al., 2007; Sanchez-Moreno et al., 2008). The 
recall of hypomania and reproducibility of MDQ could be influenced by the severity 
of past mood symptoms (Gervasoni et al., 2009). It was possible that the bipolar I 
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subjects in the Spanish study might have recalled the past manic episode more 
reliably than the current sample with mild hypomanic conditions.  
 
In line with previous studies (Benazzi, 2003; Miller et al., 2004; Twiss et al., 2008), 
lowering or omission of the impairment criterion of MDQ increased the sensitivity 
without significantly sacrificing the specificity. At any cut-off level, the sensitivity of 
the Chinese MDQ for bipolar II/NOS was lower than those reported in most previous 
studies (Hirschfeld et al., 2000; Isometsa et al., 2003; Weber Rouget et al., 2005; 
Chung et al., 2008; Sanchez-Moreno et al., 2008; Twiss et al., 2008). The finding was 
possibly due to differences in study population. Our subjects were selected from a 
non-specialized psychiatric setting among patients without previous diagnosis of 
bipolar disorder; while most previous studies were conducted in specialized mood 
disorder clinics and included known bipolar patients. Patients in specialized 
psychiatric settings had more prototypical and severe illness regardless of the bipolar 
subtype and better insight and knowledge about their bipolar diagnosis as a result of 
psychoeducation. Hence, they could recognize their past hypomania better than the 
previously undiagnosed bipolar II/NOS patients in our study. The optimal cut-off in 
this study was also lower compared to most previous studies, but it was closest to an 
Italian study conducted in a similar general psychiatric outpatient setting (Hardoy et 
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al., 2005). Cultural factors may also influence the MDQ’s screening performance. The 
Chinese tend to have stigma, negative attitudes, and misconception toward mental 
illness and low perceived need for psychiatric treatment (Ng, 1997; Lee et al., 2007). 
This may possibly result in denial of hypomanic symptoms among Chinese subjects, 
leading to underreporting during questionnaire completion. A recent study in 
Germany found that young people’s attitudes toward mania were more negative than 
for depression (Wolkenstein and Meyer, 2008); however, no study has been conducted 
in the Chinese population. Future cross-cultural studies on the attitudes and 
knowledge toward bipolar disorder are needed. The finding that the psychometric 
performance of the Chinese MDQ being similar to that of the Korean MDQ in 
depressed outpatients without previous bipolar diagnosis (Kim et al., 2008) supported 
our hypothesis that the sensitivity of MDQ was dependent on the study population 
and cultural factor. 
 
The Chinese HCL-32 had a high internal consistency that was comparable to previous 
reports (Angst et al., 2005; Wu et al., 2008). The test-retest reliability was similar to 
that of the Spanish HCL-32 (Vieta et al., 2007). The sensitivity of Chinese HCL-32 
for bipolar II/NOS at the original cut-off score of 14 was slightly lower than the 
Taiwanese and Spanish HCL-32 (Vieta et al., 2007; Wu et al., 2008). The optimal 
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cut-off score in our study was also lower than those obtained in previous studies 
(Angst et al., 2005; Vieta et al., 2007; Wu et al., 2008; Forty et al., 2009). The lower 
sensitivity and optimal cut-off in our study relative to other versions could also be due 
to differences in study population. Our optimal cut-off score of HCL-32 was 11 
(sensitivity 0.84; specificity 0.70), which was most comparable to the optimal cut-off 
score of 12 for bipolar II in a non-specialized psychiatric setting (sensitivity 0.80; 
specificity 0.54) (Carta et al., 2006). 
 
In line with previous studies (Carta et al., 2006; Vieta et al., 2007), we found that the 
Chinese HCL-32 had better discriminatory power and was more sensitive in detecting 
hypomanic conditions compared to MDQ. There are two possible reasons for the 
superiority of HCL-32 over MDQ in screening for the milder forms of bipolar 
disorder. Firstly, the development of MDQ and HCL-32 is based on different concepts. 
The MDQ is built on the ‘categorical’ concept of DSM-IV; while the HCL-32 is based 
on the ‘dimensional’ approach of bipolarity and has a wider range of hypomanic 
symptoms (Phelps and Ghaemi, 2006). Secondly, the questions of HCL-32 are 
descriptive and non-stigmatizing; while some items in MDQ tend to portray severe 
psychopathology and can be perceived by patients as signs of severe mental illness 
(Angst, 2008). 
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Our study replicated the findings in previous Western and Asian studies that bipolar 
family history in first-degree relatives was a clinical indicator of bipolarity (Benazzi, 
2007; Kim et al., 2008; Mak, 2009). A previous study found that bipolar family 
history was the strongest validator of bipolar II disorder (Benazzi and Akiskal, 2008). 
We showed that the absence of a family history of bipolar disorder had a high 
specificity, supporting its usefulness in ruling out bipolarity (Benazzi, 2004). Unlike 
most Western studies, we found that early onset of mood symptoms was not 
associated with bipolar disorder. The Chinese might have later age of onset of mood 
disorders (Lee et al., 2007); hence the definition of early-onset could be different 
between Chinese and Western populations. Further research is needed to compare the 
age of onset of mood symptoms between the Chinese and Western patients with 
bipolar disorder. Our finding that bipolar disorder was more common among younger 
subjects was in line with previous epidemiological and clinical studies (Merikangas et 
al., 2007; Lee et al., 2009; Mak, 2009). However, the association between bipolar 
disorder and educational level was still inconclusive according to a systematic review 
(Tsuchiya et al., 2003).  
 
Our study has a number of strengths as well as several methodological limitations. We 
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used a large and representative sample of general psychiatric outpatients and included 
patients with common comorbidities of bipolar disorder; hence our sample is 
representative of the real-life setting where bipolar disorder is commonly 
unrecognized. The major limitation was the use of SCID alone for diagnosis of 
bipolar disorder. Although the same methodology was adopted in previous MDQ and 
HCL-32 validation studies, future studies utilizing collateral information would 
improve our understanding of the scales’ actual performance. Another limitation was 
that psychiatric diagnoses other than mood disorders and alcohol or substance use 
disorder were derived only from medical record. Although DSM-IV Axis I and II 
comorbidity may not influence the screening performance of MDQ and HCL-32 
(Meyer et al., 2011), the under-recognition of psychiatric comorbidity in this study 
undermined our finding that psychiatric comorbidity was not a clinical predictor of 
bipolar disorder. Standardized instruments for assessing age of onset of illness and 
family history of mood disorders were not used, although efforts had been made to 
verify the clinical information during telephone interview. In addition, we had not 
examined the family history of other psychiatric disorders, which may have an 
association with bipolar disorder. The subjects were considered clinically stable at the 
time of recruitment; however, standardized rating scales were not used to quantify 
their mood during the administration of questionnaires. Although some researchers 
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have cautioned that moderately or severely depressed patients may underreport their 
previous hypomanic symptoms, a recent study showed that in subjects who had 
remitted from a severe depressive episode the MDQ total score did not significantly 
change over time (Gervasoni et al., 2009). Lastly, a single SCID rater might have 
introduced diagnostic bias; however, the semi-structured format and excellent 
inter-rater reliability of the SCID supported the diagnostic accuracy in this study. 
 
In conclusion, compared to using MDQ, HCL-32 and bipolar family history alone, 
simultaneous use of HCL-32 and family history was the best approach for screening 
bipolar disorder in a general psychiatric setting in Hong Kong. This screening method 
could detect most of the previously unrecognized bipolar disorder with satisfactory 
specificity and low false-negative rate. This approach only requires around 10 minutes 
to complete, so it is potentially useful in busy outpatient settings. Future studies 
should evaluate the screening of bipolar disorder in non-psychiatric populations. This 
is particularly relevant for HCL-32, which has not been validated in community and 
family medicine settings. 
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Table 1. Comparison between bipolar and non-bipolar subjects on demographic and clinical 
variables 
 
Variables 
Total 
(n = 305) 
Bipolar 
(n = 31) 
Non-bipolar 
(n = 274) 
P valuea n (%) n (%) n (%) 
     
Female gender 204 (66.9) 17 (54.8) 187 (68.2) 0.13 
Educational level    0.002 
 Below secondary 108 (35.4) 3 (9.7) 105 (38.3)  
 Secondary or above 197 (64.6) 28 (90.3) 169 (61.7)  
Marital status    0.83 
 Single/divorced/widowed 103 (33.8) 11 (35.5) 92 (33.6)  
 Married/cohabited 202 (66.2) 20 (64.5) 182 (66.4)  
Occupation    0.98 
 Unemployed 74 (24.3) 7 (22.6) 67 (24.5)  
 Homemaker 83 (27.2) 8 (25.8) 75 (27.4)  
 Labour worker 65 (21.3) 6 (19.4) 59 (21.5)  
 Business/clerk 57 (18.7) 7 (22.6) 50 (18.2)  
 Semi-/professional 26 (8.5) 3 (9.7) 23 (8.4)  
Monthly household incomeb    0.10 
 On government subsidies 67 (22.3) 5 (16.7) 62 (23.0)  
 Low income group  
(≤ HK$20000) 
 
169 (56.3) 
 
14 (46.7) 
 
155 (57.4) 
 
 High income group  
(> HK$20000) 
 
64 (21.3) 
 
11 (36.7) 
 
53 (19.6) 
 
Positive family history in 
first-degree relatives 
    
 Bipolar disorder 25 (8.2) 7 (22.6) 18 (6.6) 0.007 
 Depressive disorder 64 (21.0) 8 (25.8) 56 (20.4) 0.49 
Psychiatric comorbidity     
 Axis I and II comorbidity 
by medical record 
 
16 (5.2) 
 
2 (6.5) 
 
14 (5.1) 
 
0.67 
 Substance/alcohol use 
disorder by SCID 
 
23 (7.5) 
 
2 (6.5) 
 
21 (7.7) 
 
1.00 
     
 median (range) 
(mean ± SD) 
median (range) 
(mean ± SD) 
median (range) 
(mean ± SD) P valuec 
Age 
      
50.0 (18-64) 
(48.9 ± 9.6) 
44.0 (18-62) 
(44.1 ± 9.2) 
50.5 (23-64) 
(49.4 ± 9.5) 
0.002 
Age of onset of illness  
      
37.0 (10-60) 
(37.4 ± 10.7) 
34.0 (10-60) 
(33.9 ± 10.9) 
38.5 (12-60) 
(37.8 ± 10.6) 
0.057 
MDQ total score 
      
3.0 (0-13) 
(3.2 ± 2.5) 
5.0 (1-13) 
(5.8 ± 3.2) 
3.0 (0-10) 
(2.9 ± 2.2) 
<0.001 
HCL-32 total score 
   
8.0 (0-27) 
(8.9 ± 6.6) 
17.0 (2-25) 
(15.7 ± 6.2) 
7.0 (0-27) 
(8.1 ± 6.2) 
<0.001 
 
a P value by Pearson chi-square or Fisher’s exact test. 
b n = 300 due to missing data (bipolar group, n = 30; non-bipolar group, n = 270). 
c P value by Mann-Whitney U test.
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Table 2. Comparison of screening performance for combination of Chinese MDQa and 
HCL-32 b at optimal cut-offs and bipolar family history 
 
Screening method  Sensitivity Specificity PPV NPV LR(+) LR(-) 
       
MDQ alone 0.65 0.77 0.24 0.95 2.83 0.45 
HCL-32 alone 0.84 0.70 0.24 0.98 2.80 0.23 
Bipolar family history alone 0.23 0.93 0.28 0.91 3.29 0.83 
MDQ and bipolar family history  
(either one positive) 
 
0.71 
 
0.72 
 
0.22 
 
0.96 
 
2.54 
 
0.40 
HCL-32 and bipolar family 
history (either one positive) 
 
0.90 
 
0.67 
 
0.24 
 
0.98 
 
2.73 
 
0.15 
  
a Optimal cut-off criteria of MDQ in this population is ≥ 4 positive items, symptom clustering 
and omission of impairment criterion. 
b Optimal cut-off criteria of HCL-32 in this population is ≥ 11 positive items. 
PPV = Positive predictive value; NPV = Negative predictive value; LR(+) = Positive 
likelihood ratio; LR(-) = Negative likelihood ratio.
  
29 
Figure 1. Receiver operating characteristic curves of Chinese MDQ at six different 
cut-off levels. 
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Figure 2. Receiver operating characteristic curve of Chinese HCL-32 
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